Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease

被引:77
作者
Jones, SM
Harris, CPD
Lloyd, J
Stirling, CA
Reckless, JPD
McHugh, NJ
机构
[1] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England
[2] Bath Inst Rheumat Dis, Bath BA1 1HD, Avon, England
[3] Royal United Hosp, Diabet & Lipid Res Grp, Bath BA1 3NG, Avon, England
关键词
D O I
10.1136/ard.59.11.904
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives-(a) To characterise the lipid profile in psoriatic arthritis and investigate whether there are similarities to the dyslipoproteinaemia reported in rheumatoid arthritis and other inflammatory forms of joint disease; (b) to investigate whether there is an atherogenic lipid profile in psoriatic arthritis, which may have a bearing on mortality. Methods-Fasting lipids, lipoproteins, and their subfractions were measured in 50 patients with psoriatic arthritis and their age and sex matched controls. Results-High density lipoprotein cholesterol (HDL cholesterol) and its third subfraction, HDL3 cholesterol, were significantly reduced and the most dense subfraction of low density lipoprotein (LDL), LDL3, was significantly increased in the patients with psoriatic arthritis. Twenty patients with active synovitis had significantly lower total cholesterol, LDL cholesterol, and HDL3 cholesterol than their controls. 25% of the patients with psoriatic arthritis had raised Lp(a) Lipoprotein levels (>300 mg/l) compared with 19% of controls, but this was not statistically significant. Conclusion-Raised levels of LDL3 and low levels of HDL cholesterol are associated with coronary artery disease. Such an atherogenic profile in a chronic inflammatory form of arthritis is reported, which may be associated with accelerated mortality.
引用
收藏
页码:904 / 909
页数:6
相关论文
共 33 条
[11]   FACTORS INFLUENCING THE LOW-DENSITY-LIPOPROTEIN PROFILE IN TYPE-2 DIABETIC-PATIENTS [J].
JAMES, RW ;
MARINI, M ;
RUIZ, J ;
POMETTA, D .
DIABETIC MEDICINE, 1995, 12 (01) :61-65
[12]   DYSLIPOPROTEINEMIA IN THE COURSE OF ACTIVE RHEUMATOID-ARTHRITIS [J].
LAZAREVIC, MB ;
VITIC, J ;
MLADENOVIC, V ;
MYONES, BL ;
SKOSEY, JL ;
SWEDLER, WI .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 22 (03) :172-180
[13]  
LINDGREN FT, 1972, BLOOD LIPIDS LIPOPRO, V5, P182
[14]   SERUM CHOLESTEROL IN RHEUMATIC DISEASES [J].
LONDON, MG ;
MUIRDEN, KD ;
HEWITT, JV .
BMJ-BRITISH MEDICAL JOURNAL, 1963, (534) :1380-+
[15]  
LORBER M, 1985, BRIT J RHEUMATOL, V24, P250
[16]   LIPOPROTEIN (A) AND CORONARY HEART-DISEASE [J].
MAHER, VMG ;
BROWN, BG .
CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (04) :229-235
[17]  
NIGON F, 1991, J LIPID RES, V32, P1741
[18]   CACHECTIN TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 SHOW DIFFERENT MODES OF COMBINED EFFECT ON LIPOPROTEIN-LIPASE ACTIVITY AND INTRACELLULAR LIPOLYSIS IN 3T3-L1 CELLS [J].
OGAWA, H ;
NIELSEN, S ;
KAWAKAMI, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1003 (02) :131-135
[19]  
Pincus T, 1995, BRIT J RHEUMATOL, V34, P59
[20]   LIPOPROTEIN-(A), LIPIDS, AND LIPOPROTEINS IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
RANTAPAADAHLQVIST, S ;
WALLBERGJONSSON, S ;
DAHLEN, G .
ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (06) :366-368